INVA News and Press, Innoviva Inc. From 08/14/23

2023-08-14 08:15:00 ET Summary This article provides a dashboard with industry metrics in healthcare, then focus on the Global X Genomics & Biotechnology ETF. Pharmaceuticals/biotechnology and healthcare providers have fair value and quality scores. Healthcare equipment is...

2023-08-02 17:26:02 ET Innoviva press release ( NASDAQ: INVA ): Q2 GAAP EPS of $0.02. Revenue of $80.99M (-25.2% Y/Y) beats by $13.07M . For further details see: Innoviva GAAP EPS of $0.02, revenue of $80.99M beats by $13.07M

Received GSK royalties of $65.7 million, net product revenues of $15.7 million and license revenue of $3.0 million in the second quarter of 2023 Received FDA approval for XACDURO® for treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia cau...

2023-07-19 11:00:00 ET Summary Pharmaceuticals/biotechnology is the most attractive subsector regarding both value and quality scores. Healthcare equipment is the most overpriced healthcare industry. Fast facts on iShares U.S. Healthcare ETF. 10 healthcare stocks cheaper t...

Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics PR Newswire Signs new $25 million credit agreement and extension of existing secured convertible credit agreement Appoints world‐renowned ...

2023-06-21 15:17:56 ET Summary Innoviva Inc. shares have slightly outperformed the S&P 500, returning about 12% against a gain of about 10.8% for the S&P 500. The company has promising developments and the financials are "fine," but the shares are not cheap, making the ris...

2023-06-19 05:16:46 ET Summary Pharma/biotechnology and healthcare providers are slightly undervalued relative to 11-year averages. Healthcare equipment is the most overvalued subsector. Fast facts on PBE, a genomics ETF. 10 healthcare stocks cheaper than their peers in Ju...

Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and other healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will present at the Goldman Sachs Annual Global Healthcare Conference in Dana Point, CA o...

2023-05-26 15:00:30 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...

2023-05-24 06:03:52 ET Innoviva ( NASDAQ: INVA ) said the the U.S. Food and Drug Administration (FDA) approved bacterial pneumonia therapy Xacduro. The new drug application (NDA) for Xacduro (sulbactam for injection; durlobactam for injection) was filed by Entasis Th...